PMID: 6984982Jan 1, 1982Paper

Use of Haemonetics Cell Saver for autotransfusion in cardiovascular surgery

Scandinavian Journal of Thoracic and Cardiovascular Surgery
S Ottesen, T Frøysaker

Abstract

The Haemonetics Cell Saver was evaluated as a tool for the refining of blood shed during cardiovascular surgery. After blood filtration the red cells are concentrated, washed and re-infused as red cells suspended in normal saline (CS blood) with haematocrit around 60%. Platelets and plasma with desired and undesired components are removed. In 50 patients undergoing elective but complicated cardiovascular surgery an average of 4.4 units CS blood were produced. In 3 Jehovah's Witnesses the method was used in combination with immediate preoperative prebleeding and dextran infusion. No blood products were given. The haematocrit was maintained at a safe level subsequent to retransfusion. Platelet counts were never critically low and extremely low total protein did not lead to peripheral or pulmonary oedemas or coagulation problems. In an in vitro study it was shown that extreme dilution of coagulation factors is well tolerated before the clotting time (ACT) is affected. The Cell Saver proved to be an effective, reliable and safe device for autotransfusion of salvaged blood during cardiovascular surgery.

References

Sep 19, 1977·JAMA : the Journal of the American Medical Association·D A Ott, D A Cooley
Apr 1, 1979·Scandinavian Journal of Clinical and Laboratory Investigation·P Lilleaasen, O Stokke
Jan 1, 1978·Cleveland Clinic Quarterly·L H Cohn
Apr 1, 1977·The Annals of Thoracic Surgery·P V KamatD C Finlayson
Jan 1, 1977·Clinical Toxicology·L P Hackett, L J Dusci
Jan 1, 1976·Scandinavian Journal of Thoracic and Cardiovascular Surgery·M KveimK V Hall
Feb 3, 1975·JAMA : the Journal of the American Medical Association·P B YawJ L GGlover
Nov 1, 1974·Transfusion·J LubinE Paul
Sep 1, 1973·Journal of Medical Genetics·T Helske, H R Nevanlinna
May 2, 1966·JAMA : the Journal of the American Medical Association·P G Hattersley
May 1, 1981·The Annals of Thoracic Surgery·A R Cordell, S W Lavender
Jan 1, 1980·Langenbecks Archiv für Chirurgie·J WenigerJ Blechschmidt
Jan 1, 1981·Transfusion·J Umlas, T P O'Neill
Jan 1, 1818·Medico-chirurgical Transactions·J Blundell

❮ Previous
Next ❯

Citations

Mar 21, 2000·Transfusion Science·K T Murto, W M Splinter
Jun 20, 2002·Transfusion Medicine·J F BurmanJ R Pepper
May 1, 1995·Acta Anaesthesiologica Scandinavica·J PerttiläM Salo
Dec 1, 1995·Intensive Care Medicine·M KristianssonM Blomback
May 16, 2006·Thoracic Surgery Clinics·Ryan C Fields, Bryan F Meyers
Oct 1, 1991·Journal of Cardiothoracic and Vascular Anesthesia·D ParrotB Caillard
Feb 3, 2015·Frontiers in Physiology·Joseph M RifkindEnika Nagababu
Sep 7, 2016·Journal of Cardiothoracic and Vascular Anesthesia·Willem Frederik BuysAndrew Ian Levin
Jan 1, 1984·Scandinavian Journal of Thoracic and Cardiovascular Surgery·S OttesenK Hatteland
Jan 1, 1987·Scandinavian Journal of Thoracic and Cardiovascular Surgery·J O SolemC Olin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Aneurysm

Aneurysm refers to a bulge of the wall or lining of a vessel commonly occurring in the blood vessels at the base of the septum or within the aorta. In the heart, it usually arises from a patch of weakened tissue in a ventricular wall, which swells into a bubble filled with blood. Discover the latest research on cardiac aneurysm here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.